Location History:
- St. Ives, AU (2008 - 2011)
- Ultimo, AU (2022)
Company Filing History:
2 out of 3 
2 out of 32 
1 out of 3 Years Active: 2008-2022
Title: Innovator Spotlight: Michael Wallach
Introduction
Michael Wallach, an accomplished inventor based in St. Ives, Australia, has made significant contributions to the field of biotechnology. With a portfolio of four patents, Wallach's work focuses on innovative solutions for health-related challenges.
Latest Patents
Among his latest patents is a groundbreaking development related to nanoparticles adsorbed with gliadin molecules. This invention deals with nanoparticles designed for detecting anti-gliadin 5 antibodies, diagnosing gluten-related disorders, and various other applications. Another notable patent involves the recombinant cloning and sequencing of two major gametocyte antigens with molecular weights of 56 kDa and 82 kDa. This invention also encompasses a vaccine against coccidiosis, combining the recombinant antigens with additional proteins for enhanced immunization methodologies.
Career Highlights
Michael Wallach has built a robust career with tenures at several reputable organizations. He has worked with Abic Biological Laboratories, Teva Ltd., and the University of Technology Sydney, where he applied his expertise in biotechnology and patent development.
Collaborations
Throughout his career, Wallach has collaborated with notable professionals in his field, including Nicholas C. Smith and Sabina I. Belli. These partnerships have contributed to the advancement and implementation of his innovative ideas.
Conclusion
Michael Wallach is a distinguished inventor whose pioneering work in biotechnology continues to influence various sectors, particularly in health diagnostics and treatment. With a notable list of patents and collaborations, he remains a significant figure in the innovation landscape, contributing solutions that address critical health issues.